The future of pain medication: are cannabinoids the solution to the opioid epidemic?
Pharmaceutical Technology
JUNE 12, 2023
CB1 is predominantly found in the central and peripheral nervous system, whereas CB2 is primarily located in immune cells. Currently, Jazz Pharmaceuticals’s nabiximols is the only cannabinoid approved for pain, receiving approval in Israel, in August 2010.
Let's personalize your content